What imaging features raise suspicion for a primary brain tumor, and what are common presentations?

What imaging features raise suspicion for a primary brain tumor, and what are common presentations?

• A. Diffuse atrophy without a focal mass
• B. No edema
• C. New focal deficits, headaches worse at night, and seizures; MRI may show a mass with edema and ring-enhancing lesion; histology is required for diagnosis
• D. Mass is always benign

Answer: (C)

The main idea is that brain tumors typically present with new focal neurologic signs and seizures, and imaging shows a localized mass often accompanied by edema and contrast enhancement, with histology needed to confirm the diagnosis. When a patient develops new focal deficits, headaches that can worsen with increased intracranial pressure (sometimes at night), and seizures, these symptoms point toward a focal brain process rather than a diffuse or degenerative condition. On MRI, a mass with surrounding edema reflects tumor-related vasogenic edema and mass effect, and ring enhancement indicates disruption of the blood–brain barrier with central necrosis—a pattern commonly seen in malignant tumors. Importantly, imaging alone cannot tell you the exact tumor type, so tissue diagnosis via histology is required to confirm and guide management. Other options don’t fit because diffuse atrophy without a focal mass lacks a lesion to explain focal deficits; absence of edema is not typical for a tumor; and stating that masses are always benign ignores that many primary brain tumors are malignant and cause edema and mass effect.

The main idea is that brain tumors typically present with new focal neurologic signs and seizures, and imaging shows a localized mass often accompanied by edema and contrast enhancement, with histology needed to confirm the diagnosis. When a patient develops new focal deficits, headaches that can worsen with increased intracranial pressure (sometimes at night), and seizures, these symptoms point toward a focal brain process rather than a diffuse or degenerative condition. On MRI, a mass with surrounding edema reflects tumor-related vasogenic edema and mass effect, and ring enhancement indicates disruption of the blood–brain barrier with central necrosis—a pattern commonly seen in malignant tumors. Importantly, imaging alone cannot tell you the exact tumor type, so tissue diagnosis via histology is required to confirm and guide management. Other options don’t fit because diffuse atrophy without a focal mass lacks a lesion to explain focal deficits; absence of edema is not typical for a tumor; and stating that masses are always benign ignores that many primary brain tumors are malignant and cause edema and mass effect.